BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin D, Shen L, Luo M, Zhang K, Li J, Yang Q, Zhu F, Zhou D, Zheng S, Chen Y, Zhou J. Circulating tumor cells: biology and clinical significance. Signal Transduct Target Ther 2021;6:404. [PMID: 34803167 DOI: 10.1038/s41392-021-00817-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 47] [Article Influence: 37.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou X, Bai D, Yu H, Fu Y, Song L, Wu Y, Chen K, Li J, Yang Y, Chen H, Wang Z, Xie G. Detection of rare CTCs by electrochemical biosensor built on quaternary PdPtCuRu nanospheres with mesoporous architectures. Talanta 2023;253:123955. [DOI: 10.1016/j.talanta.2022.123955] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Li X, Ma S, Gao T, Mai Y, Song Z, Yang J. The main battlefield of mRNA vaccine – Tumor immune microenvironment. International Immunopharmacology 2022;113:109367. [DOI: 10.1016/j.intimp.2022.109367] [Reference Citation Analysis]
3 Pekarek L, De la Torre-escuredo B, Fraile-martinez O, García-montero C, Saez MA, Cobo-prieto D, Guijarro LG, Saz JV, De Castro-martinez P, Torres-carranza D, Pekarek T, Carrera AC, Alvarez-mon M, Ortega MA. Towards the Search for Potential Biomarkers in Osteosarcoma: State-of-the-Art and Translational Expectations. IJMS 2022;23:14939. [DOI: 10.3390/ijms232314939] [Reference Citation Analysis]
4 Pacelli P, Raspadori D, Bestoso E, Gozzetti A, Bocchia M. “Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1057713] [Reference Citation Analysis]
5 Völlmecke K, Afroz R, Bierbach S, Brenker LJ, Frücht S, Glass A, Giebelhaus R, Hoppe A, Kanemaru K, Lazarek M, Rabbe L, Song L, Velasco Suarez A, Wu S, Serpe M, Kuckling D. Hydrogel-Based Biosensors. Gels 2022;8:768. [DOI: 10.3390/gels8120768] [Reference Citation Analysis]
6 Petrik J, Verbanac D, Fabijanec M, Hulina-tomašković A, Čeri A, Somborac-bačura A, Petlevski R, Grdić Rajković M, Rumora L, Krušlin B, Štefanović M, Ljubičić N, Baršić N, Hanžek A, Bočkor L, Ćelap I, Demirović A, Barišić K. Circulating Tumor Cells in Colorectal Cancer: Detection Systems and Clinical Utility. IJMS 2022;23:13582. [DOI: 10.3390/ijms232113582] [Reference Citation Analysis]
7 Galoș D, Gorzo A, Balacescu O, Sur D. Clinical Applications of Liquid Biopsy in Colorectal Cancer Screening: Current Challenges and Future Perspectives. Cells 2022;11:3493. [DOI: 10.3390/cells11213493] [Reference Citation Analysis]
8 Guillorit H, Relier S, Zagiel B, Di Giorgio A, Cazevieille C, Bansard L, Bouclier C, Mialhe X, Brisset M, Hideg S, Choquet A, Planque C, Bastide A, Pannequin J, Duca M, Macari F, David A. The aminoglycoside streptomycin triggers ferroptosis in tumor initiating cells.. [DOI: 10.1101/2022.10.31.514281] [Reference Citation Analysis]
9 Doyle-lindrud S. Personalized cancer care. J Am Assoc Nurse Pract 2022;34:1184-1186. [DOI: 10.1097/jxx.0000000000000793] [Reference Citation Analysis]
10 Smolkova B, Kataki A, Earl J, Ruz-caracuel I, Cihova M, Urbanova M, Buocikova V, Tamargo S, Rovite V, Niedra H, Schrader J, Kohl Y. Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms. Critical Reviews in Oncology/Hematology 2022. [DOI: 10.1016/j.critrevonc.2022.103865] [Reference Citation Analysis]
11 Li C, Li R, Wu X, Zuo Y, Xiong G, Huang M, Sun Y, Liao R, Xiao Y, Hu L, Gao C, Yu Y. Capture of Heterogeneous Circulating Tumor Cells in Colorectal Cancer Patients on an Immunomagnetic and Anti-Nonspecific Adsorption Platform. Anal Chem 2022. [DOI: 10.1021/acs.analchem.2c02416] [Reference Citation Analysis]
12 Silva ATF, Rodrigues CM, Ferreira ICC, Santos LLD, Santos DW, Araújo TG, Canto PPL, Paiva CE, Goulart LR, Maia YCP. A Novel Detection Method of Breast Cancer through a Simple Panel of Biomarkers. Int J Mol Sci 2022;23. [PMID: 36233281 DOI: 10.3390/ijms231911983] [Reference Citation Analysis]
13 Yuan M, Liu L, Wang C, Zhang Y, Zhang J. The Complement System: A Potential Therapeutic Target in Liver Cancer. Life (Basel) 2022;12:1532. [PMID: 36294966 DOI: 10.3390/life12101532] [Reference Citation Analysis]
14 Geus PF, Hehnen F, Krakowski S, Lücke K, Hoon DSB, Frost N, Kertzscher U, Wendt G. Verification of a Novel Minimally Invasive Device for the Isolation of Rare Circulating Tumor Cells (CTC) in Cancer Patients’ Blood. Cancers 2022;14:4753. [DOI: 10.3390/cancers14194753] [Reference Citation Analysis]
15 Kobayashi S, Sugasaki A, Yamamoto Y, Shigenoi Y, Udaka A, Yamamoto A, Tanaka M. Enrichment of Cancer Cells Based on Antibody-Free Selective Cell Adhesion. ACS Biomater Sci Eng 2022. [PMID: 36153975 DOI: 10.1021/acsbiomaterials.2c00662] [Reference Citation Analysis]
16 Luo M, Li J, Yang Q, Xu S, Zhang K, Chen J, Zhang S, Zheng S, Zhou J. N4BP3 promotes breast cancer metastasis via NEDD4-mediated E-cadherin ubiquitination and degradation. Cancer Lett 2022;:215926. [PMID: 36162713 DOI: 10.1016/j.canlet.2022.215926] [Reference Citation Analysis]
17 Liu Z, Gu Y, Yu F, Zhou L, Cheng X, Jiang H, Huang Y, Zhang Y, Xu T, Qian W, Li X. The Number of Intraoperative Intestinal Venous Circulating Tumor Cells Is a Prognostic Factor for Colorectal Cancer Patients. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-13. [DOI: 10.1155/2022/4162354] [Reference Citation Analysis]
18 Liang Y, Wang Q, Zhang X, Zhang M, Du B, Cheng W, Wang H, Li L, Hou G, Zhang W. Dual isothermal amplification all-in-one approach for rapid and highly sensitive quantification of plasma circulating MYCN gene of neuroblastoma. Anal Biochem 2022;:114922. [PMID: 36162447 DOI: 10.1016/j.ab.2022.114922] [Reference Citation Analysis]
19 Komarnicki P, Musiałkiewicz J, Stańska A, Maciejewski A, Gut P, Mastorakos G, Ruchała M. Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future. JCM 2022;11:5542. [DOI: 10.3390/jcm11195542] [Reference Citation Analysis]
20 Jang A, Rauterkus GP, Vaishampayan UN, Barata PC. Overcoming Obstacles in Liquid Biopsy Developments for Prostate Cancer. Onco Targets Ther 2022;15:897-912. [PMID: 36051571 DOI: 10.2147/OTT.S285758] [Reference Citation Analysis]
21 Wu S, Zhao S, Cui D, Xie J, Qian L. Advances in the Biology, Detection Techniques, and Clinical Applications of Circulating Tumor Cells. Journal of Oncology 2022;2022:1-14. [DOI: 10.1155/2022/7149686] [Reference Citation Analysis]
22 Chantre-justino M, Alves G, Delmonico L. Clinical applications of liquid biopsy in HPV‐negative and HPV‐positive head and neck squamous cell carcinoma: advances and challenges. Exploration of Targeted Anti-tumor Therapy 2022. [DOI: 10.37349/etat.2022.00099] [Reference Citation Analysis]
23 Yang G, Lu T, Weisenberger DJ, Liang G. The Multi-Omic Landscape of Primary Breast Tumors and Their Metastases: Expanding the Efficacy of Actionable Therapeutic Targets. Genes 2022;13:1555. [DOI: 10.3390/genes13091555] [Reference Citation Analysis]
24 Arafa KK, Ibrahim A, Mergawy R, El-sherbiny IM, Febbraio F, Hassan RYA. Advances in Cancer Diagnosis: Bio-Electrochemical and Biophysical Characterizations of Cancer Cells. Micromachines 2022;13:1401. [DOI: 10.3390/mi13091401] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Rousset X, Maillet D, Grolleau E, Barthelemy D, Calattini S, Brevet M, Balandier J, Raffin M, Geiguer F, Garcia J, Decaussin-petrucci M, Peron J, Benzerdjeb N, Couraud S, Viallet J, Payen L. Embryonated Chicken Tumor Xenografts Derived from Circulating Tumor Cells as a Relevant Model to Study Metastatic Dissemination: A Proof of Concept. Cancers 2022;14:4085. [DOI: 10.3390/cancers14174085] [Reference Citation Analysis]
26 Li A, He X, Wu J, Zhang J, Xu G, Xu B, Zhao G, Shen Z. Ultrathin silicon nitride membrane with slit-shaped pores for high-performance separation of circulating tumor cells. Lab Chip 2022. [PMID: 35997043 DOI: 10.1039/d2lc00703g] [Reference Citation Analysis]
27 Wu Y, Zhou Y, Paul R, Qin X, Islam K, Liu Y. Adaptable Microfluidic Vessel-on-a-Chip Platform for Investigating Tumor Metastatic Transport in Bloodstream. Anal Chem 2022. [PMID: 35998619 DOI: 10.1021/acs.analchem.2c02556] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Huang J, Lu A, Liang C. Deciphering and Targeting Epigenetics in Cancer Metastasis. Cancer Metastasis - Molecular Mechanism and Clinical Therapy [Working Title] 2022. [DOI: 10.5772/intechopen.106584] [Reference Citation Analysis]
29 Koguchi D, Matsumoto K, Shiba I, Harano T, Okuda S, Mori K, Hirano S, Kitajima K, Ikeda M, Iwamura M. Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A Review. IJMS 2022;23:9148. [DOI: 10.3390/ijms23169148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Mokini Z, Cama A, Forget P. Anesthetics and Long Term Cancer Outcomes: May Epigenetics Be the Key for Pancreatic Cancer? Medicina (Kaunas) 2022;58:1102. [PMID: 36013569 DOI: 10.3390/medicina58081102] [Reference Citation Analysis]
31 Moghimi SM, Schwartz S. Striking Circulating Tumour Cells during Sleep. JNT 2022;3:132-133. [DOI: 10.3390/jnt3030009] [Reference Citation Analysis]
32 Panovska D, De Smet F. Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome? IJMS 2022;23:8637. [DOI: 10.3390/ijms23158637] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Nascentes Melo LM, Lesner NP, Sabatier M, Ubellacker JM, Tasdogan A. Emerging metabolomic tools to study cancer metastasis. Trends Cancer 2022:S2405-8033(22)00156-X. [PMID: 35909026 DOI: 10.1016/j.trecan.2022.07.003] [Reference Citation Analysis]
34 Sattar RSA, Verma R, Nimisha, Kumar A, Dar GM, Apurva, Sharma AK, Kumari I, Ahmad E, Ali A, Mahajan B, Saluja SS. Diagnostic and prognostic biomarkers in colorectal cancer and the potential role of exosomes in drug delivery. Cell Signal 2022;:110413. [PMID: 35907519 DOI: 10.1016/j.cellsig.2022.110413] [Reference Citation Analysis]
35 Tang HD, Wang Y, Xie P, Tan SY, Li HF, Shen H, Zhang Z, Lei ZQ, Zhou JH. The Crosstalk Between Immune Infiltration, Circulating Tumor Cells, and Metastasis in Pancreatic Cancer: Identification of HMGB3 From a Multiple Omics Analysis. Front Genet 2022;13:892177. [PMID: 35754798 DOI: 10.3389/fgene.2022.892177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Amantini C, Maggi F, Rossi de Vermandois JA, Gubbiotti M, Giannantoni A, Mearini E, Nabissi M, Tomassoni D, Santoni G, Morelli MB. The Prognostic Value of the Circulating Tumor Cell-Based Four mRNA Scoring System: A New Non-Invasive Setting for the Management of Bladder Cancer. Cancers 2022;14:3118. [DOI: 10.3390/cancers14133118] [Reference Citation Analysis]
37 Rahman M, Islam KR, Islam MR, Islam MJ, Kaysir MR, Akter M, Rahman MA, Alam SMM. A Critical Review on the Sensing, Control, and Manipulation of Single Molecules on Optofluidic Devices. Micromachines (Basel) 2022;13:968. [PMID: 35744582 DOI: 10.3390/mi13060968] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Fu T, Li S, Wei L, Huang S, Xue Y, Cui K. Optimal whole blood dilution protocol for preprocessing samples prior to circulating tumor cell capture by size-based isolation. J Clin Lab Anal 2022;:e24524. [PMID: 35657145 DOI: 10.1002/jcla.24524] [Reference Citation Analysis]
39 Choi YH, Hong TH, Yoon SB, Lee IS, Lee MA, Choi HJ, Choi MH, Jung ES. Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer. Biomedicines 2022;10:1289. [DOI: 10.3390/biomedicines10061289] [Reference Citation Analysis]
40 Aleman JD, Young CD, Karam SD, Wang XJ. Revisiting laminin and extracellular matrix remodeling in metastatic squamous cell carcinoma: What have we learned after more than four decades of research? Mol Carcinog 2022. [PMID: 35596706 DOI: 10.1002/mc.23417] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 De Renzi G, De Marco G, De Meo M, Del Rosso E, Gazzaniga P, Nicolazzo C. In vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity. Cancer Drug Resist 2022;5:245-60. [PMID: 35582538 DOI: 10.20517/cdr.2021.121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Aramini B, Masciale V, Arienti C, Dominici M, Stella F, Martinelli G, Fabbri F. Cancer Stem Cells (CSCs), Circulating Tumor Cells (CTCs) and Their Interplay with Cancer Associated Fibroblasts (CAFs): A New World of Targets and Treatments. Cancers 2022;14:2408. [DOI: 10.3390/cancers14102408] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
43 Rehman AU, Khan P, Maurya SK, Siddiqui JA, Santamaria-Barria JA, Batra SK, Nasser MW. Liquid biopsies to occult brain metastasis. Mol Cancer 2022;21:113. [PMID: 35538484 DOI: 10.1186/s12943-022-01577-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Garcés JJ, San-Miguel J, Paiva B. Biological Characterization and Clinical Relevance of Circulating Tumor Cells: Opening the Pandora's Box of Multiple Myeloma. Cancers (Basel) 2022;14:1430. [PMID: 35326579 DOI: 10.3390/cancers14061430] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
45 Rupp B, Ball H, Wuchu F, Nagrath D, Nagrath S. Circulating tumor cells in precision medicine: challenges and opportunities. Trends in Pharmacological Sciences 2022. [DOI: 10.1016/j.tips.2022.02.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
46 Ponomarev A, Gilazieva Z, Solovyeva V, Allegrucci C, Rizvanov A. Intrinsic and Extrinsic Factors Impacting Cancer Stemness and Tumor Progression. Cancers (Basel) 2022;14:970. [PMID: 35205716 DOI: 10.3390/cancers14040970] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
47 Pan R, Yu C, Shao Y, Hong H, Sun J, Zhang Z, Li P, Zheng M, Andreucci E. Identification of Key Genes and Pathways Involved in Circulating Tumor Cells in Colorectal Cancer. Analytical Cellular Pathology 2022;2022:1-11. [DOI: 10.1155/2022/9943571] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Carneiro A, Piairo P, Teixeira A, Ferreira D, Cotton S, Rodrigues C, Chícharo A, Abalde-cela S, Santos LL, Lima L, Diéguez L. Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients. Cells 2022;11:376. [DOI: 10.3390/cells11030376] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
49 Kakurina GV, Stakheeva M, Sereda E, Sidenko E, Cheremisina O, Choinzonov E, Kondakova I. Pilot study of the relative number of circulating tumor cells and leukocytes containing actin-binding proteins in head and neck cancer patients. J Biomed Res 2022;37:1. [DOI: 10.7555/jbr.36.20220182] [Reference Citation Analysis]
50 Cammarata G, de Miguel-perez D, Russo A, Peleg A, Dolo V, Rolfo C, Taverna S. Emerging noncoding RNAs contained in extracellular vesicles: rising stars as biomarkers in lung cancer liquid biopsy. Ther Adv Med Oncol 2022;14:175883592211312. [DOI: 10.1177/17588359221131229] [Reference Citation Analysis]